Benefit of Hemoadsorption Therapy in Patients Suffering Sepsis-Associated Acute Kidney Injury: A Case Series

医学 降钙素原 败血症 肾脏替代疗法 急性肾损伤 感染性休克 血液滤过 器官功能障碍 休克(循环) 内科学 剂量 人口 肾病科 SAPS II型 阿帕奇II 胃肠病学 血液透析 重症监护室 环境卫生
作者
Monir Sadat Hakemi,Amir Ahmad Nassiri,Ali Nobakht,Masoud Mardani,Ilad Alavi Darazam,Maziyar Parsa,Mir Mohammmad Miri,Reza Shahrami,Azadeh Ahmadi Koomleh,Kiana Entezarmahdi,Anita Karimi
出处
期刊:Blood Purification [Karger Publishers]
卷期号:51 (10): 823-830 被引量:9
标识
DOI:10.1159/000521228
摘要

Sepsis is defined as life-threatening organ dysfunction in result of the host's dysregulated response to infection and septic shock. Sepsis-associated kidney injury is usually defined as concurrent presence of acute kidney injury (AKI) and sepsis without other significant causative factors.The current retrospective study was conducted to elucidate beneficial and side effects of CytoSorb®. A total of 17 patients were primarily treated with continuous renal replacement therapy in combination with CytoSorb. The demand for norepinephrine, mean arterial pressure, lactate, and procalcitonin (PCT) levels, as well as ICU length of stay, was measured.The blood lactate levels decreased by 32.30% when comparing mean levels before and after treatment. All patients who survived (n = 14) had reduction in vasopressor demand to 68.96% of their initial dose before the start of treatment. Hospital survival was greater in patients who initially had higher vasopressor demand compared to their nonsurviving counterparts, but in whom vasopressor dosages were reduced significantly during their treatments. Mortality as predicted by APACHE II score in the overall patient population was 79.9%, whereas, the observed ICU mortality was 31%. The baseline PCT levels on patients received 1, 2, and 3 CytoSorbs were 27.08 ± 5.81 ng/mL, 13.28 ± 2.62 ng/mL, and 21.03 ± 6.56 ng/mL, respectively. Observed PCT levels at 24 h after the last treatment on patients received 1, 2, and 3 CytoSorb were 31.55 ± 15.70 ng/mL, 5.61 ± 1.77 ng/mL, and 8.11 ± 3.62 ng/mL, respectively.In conclusion, it seems that applying the CytoSorb in combination with CRRT in ICU septic patients with AKI, is related to a significant decrease in mortality, if the integrity and continuity of the treatment be kept, as much as possible. This study presented an effectively positive outcome with cytokine adsorber treatment as an adjuvant along with standard treatment in a high-risk mortality case of septic shock with organ failure.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
周声声发布了新的文献求助10
刚刚
随影相伴完成签到 ,获得积分10
刚刚
刚刚
1秒前
111123123123完成签到 ,获得积分10
1秒前
嘻嘻印完成签到,获得积分10
1秒前
凌晨五点的完成签到,获得积分10
1秒前
鲸鱼完成签到 ,获得积分10
1秒前
heavenhorse完成签到,获得积分0
1秒前
lyz发布了新的文献求助10
2秒前
neao完成签到,获得积分10
3秒前
冬瓜有内涵呐完成签到,获得积分10
3秒前
金开完成签到,获得积分10
3秒前
崩坏的幻想完成签到,获得积分10
4秒前
哈哈呀完成签到 ,获得积分10
4秒前
冰冷天蝎座完成签到,获得积分10
4秒前
冷酷青枫给冷酷青枫的求助进行了留言
4秒前
义气的慕卉完成签到,获得积分10
4秒前
俭朴的乐巧完成签到 ,获得积分20
5秒前
444完成签到,获得积分10
5秒前
甜美的夏之完成签到,获得积分10
5秒前
天真的嚓茶完成签到,获得积分10
5秒前
学术裁缝完成签到,获得积分10
5秒前
hill完成签到,获得积分10
5秒前
Rainbow完成签到,获得积分10
6秒前
落寞的又菡完成签到,获得积分10
7秒前
7秒前
白色梨花发布了新的文献求助30
7秒前
zdl完成签到,获得积分10
8秒前
teresa完成签到,获得积分10
9秒前
隐形觅翠完成签到,获得积分10
9秒前
XiaoMing完成签到,获得积分10
10秒前
嗒嗒发布了新的文献求助20
10秒前
852应助落寞的又菡采纳,获得10
11秒前
12秒前
西溪浅浅完成签到 ,获得积分10
12秒前
自由的蒜苗完成签到,获得积分10
12秒前
乖加油发布了新的文献求助20
12秒前
佳佳完成签到 ,获得积分10
12秒前
14秒前
高分求助中
Handbook of Diagnosis and Treatment of DSM-5-TR Personality Disorders 800
Algorithmic Mathematics in Machine Learning 500
Разработка метода ускоренного контроля качества электрохромных устройств 500
建筑材料检测与应用 370
Getting Published in SSCI Journals: 200+ Questions and Answers for Absolute Beginners 300
Advances in Underwater Acoustics, Structural Acoustics, and Computational Methodologies 300
The Monocyte-to-HDL ratio (MHR) as a prognostic and diagnostic biomarker in Acute Ischemic Stroke: A systematic review with meta-analysis (P9-14.010) 240
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3830672
求助须知:如何正确求助?哪些是违规求助? 3372994
关于积分的说明 10476648
捐赠科研通 3093056
什么是DOI,文献DOI怎么找? 1702310
邀请新用户注册赠送积分活动 818920
科研通“疑难数据库(出版商)”最低求助积分说明 771153